Outlook 2018 Teleconference: The Trump Administration’s Impact on Life Sciences and Health Care—the First Year

January 23, 2018
Gregory H. Levine , Kellie B. Combs ,
Albert F. Cacozza, Jr.
Thomas N. Bulleit
Colleen A. Conry
Capital Insights.

On Tuesday, January 23, Ropes & Gray hosted a teleconference on the regulatory and compliance impact of the Trump Administration’s first year on life sciences and health care companies. The discussion featured the perspectives of life sciences partners Greg Levine, Kellie Combs, Al Cacozza, health care partner Tom Bulleit and government enforcement partner Colleen Conry. The call examined various issues, including: 

  • Impact of new leadership at HHS, CMS and FDA 
  • Health care reform - the latest on The Affordable Care Act and value-based health care 
  • Developments at the FDA - new policies and guidance, FDARA and 21st Century Cures Act implementation, FDCA enforcement 
  • Enforcement update: DOJ and HHS

To listen to a recording of the teleconference, please click here.

To access the teleconference transcript, please click here.

Ropes & Gray Speakers